Gain Cities 10-K 9 Feb 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Nov. 30, 2015	Feb. 08, 2016	May. 31, 2015
Document and Entity Information:
Entity Registrant Name	Remove-By-You, Inc.
Entity Trading Symbol	RMOV
Document Type	10-K
Document Period End Date	Nov. 30, 2015
Amendment Flag	false
Entity Central Index Key	1,630,430
Current Fiscal Year End Date	--11-30
Entity Common Stock, Shares Outstanding		8,000,000
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Public Float			$ 40,000

Balance Sheets

Balance Sheets - USD ($)	Nov. 30, 2015	Nov. 30, 2014
CURRENT ASSETS:
Cash	$ 654	$ 0
Prepaid expenses	9,340	0
Total Current Assets	9,994	0
Deferred offering costs	0	0
TOTAL ASSETS	9,994	0
CURRENT LIABILITIES:
Accounts payable	39,700	2,400
Loans - related party	349	0
Loans - nonrelated parties	25,629	610
TOTAL LIABILITIES	65,678	3,010
STOCKHOLDERS' EQUITY (DEFICIT):
Preferred stock, $0.001 par value; 1,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.001 par value; 100,000,000 shares authorized; 4,000,000 shares issued and outstanding at November 30, 2015 and November 30, 2014 respectively	8,000	4,000
Additional paid in capital	12,423	0
Accumulated deficit	(76,107)	(7,010)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(55,684)	(3,010)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 9,994	$ 0

Balance Sheets Parentheticals

Balance Sheets Parentheticals - $ / shares	Nov. 30, 2015	Nov. 30, 2014
Parentheticals
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	1,000,000	1,000,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	8,000,000	4,000,000
Common Stock, shares outstanding	8,000,000	4,000,000

Statements of Operations

Statements of Operations - USD ($)	Nov. 30, 2014	Nov. 30, 2015	Nov. 30, 2015
REVENUES:
Product revenue	$ 0	$ 0	$ 0
Expenses:
Consulting services and other	2,510	43,575	45,975
Accounting, audit and public company fees	0	23,443	23,443
Administration expense	0	2,079	2,189
Amortization expense	1,000	0	1,000
Organizational expenses	3,500	0	3,500
Loss before provision for income tax	7,010	69,097	76,107
Provision for income tax	0	0	0
Net loss	$ (7,010)	$ (69,097)	$ (76,107)
Basic and diluted loss per share	$ 0	$ (0.01)	$ 0
Weighted average common shares outstanding - basic and diluted	4,000,000	5,742,466	0

Statement of Stockholders' Equi

Statement of Stockholders' Equity (Deficit) - USD ($)	Common Stock Shares	Common Stock Amount	Additional Paid-in-capital	Accumulated Deficit	Total
Balance - Shares issued for organization costs at Nov. 25, 2014	3,000,000	3,000	0	0	3,000
Shares issued for intangible asset (business plan) - November 25, 2014	1,000,000	1,000	0	0	1,000
Net loss		$ 0	$ 0	$ (7,010)	$ (7,010)
Balance at Nov. 30, 2014	4,000,000	4,000	0	(7,010)	(3,010)
Issuance of common stock - registered offering $0.01 per share	4,000,000	4,000	36,000	0	40,000
Deferred offering costs recognized offset to additional paid in capital		$ 0	$ (23,577)	$ 0	$ (23,577)
Net loss		$ 0	$ 0	$ (69,097)	$ (69,097)
Balance at Nov. 30, 2015	8,000,000	8,000	12,423	(76,107)	(55,684)

Statements of Cash Flows

Statements of Cash Flows - USD ($)	Nov. 30, 2014	Nov. 30, 2015	Nov. 30, 2015
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (7,010)	$ (76,107)	$ (69,097)
Amortization	1,000	1,000	0
Shares issued for organizational expense - services	3,000	3,000	0
Adjustments to reconcile net loss to cash (used in) operating activities:
Change in prepaid expense	0	(9,340)	(9,340)
Change in deferred offering costs	0	0	0
Change in accounts payable	2,400	39,700	37,300
Net Cash (Used in) Operating Activities	(610)	(41,747)	(41,137)
CASH FLOW FROM INVESTING ACTIVITIES	0	0	0
CASH FLOW FROM FINANCING ACTIVITIES:
Proceeds from the issuance of common stock	0	40,000	40,000
Deferred offering costs paid in cash	0	(23,577)	(23,577)
Loan proceeds from related party	0	349	349
Loan repayments to nonrelated parties	0	(12,500)	(12,500)
Loan proceeds from nonrelated parties	610	38,129	37,519
Net Cash Provided by Financing Activities	610	42,401	41,791
CHANGE IN CASH	0	654	654
CASH AT BEGINNING OF PERIOD	0	0	0
CASH AT END OF PERIOD	0	654	654
Cash paid for:
Interest	0	0	0
Income taxes	0	0	0
Non-cash investing and financing activities:
Stock issued for intangible asset - business plan	$ 1,000	$ 1,000	$ 0

ORGANIZATION

ORGANIZATION	12 Months Ended
	Nov. 30, 2015
ORGANIZATION
ORGANIZATION	NOTE 1 – ORGANIZATION Remove-By-You, Inc. (the Company) was incorporated under the laws of the State of Nevada on November 25, 2014. The Company issued 3,000,000 shares of common stock to its founder at inception in exchange for organizational costs which consisted of services. Following its formation, the Company issued 1,000,000 shares of common stock to our founder, as consideration for the purchase of a business plan along with several product formulas and an assorted selection of micro-needle devices for use in a proprietary tattoo removal business. Our founder paid approximately $1,000 for this developed product formula, along with the micro-needle devices with which he personally developed a unique program and results. The acquisition was valued at $1,000. The Company’s product formulas and tattoo removal service will use proprietary technology that will enable the user to safely remove his or her tattoo with minimal effort and discomfort. The Company’s product formula along with the micro-needle device program will safely remove the ink and design and allow the body to heal naturally without scarring. The Company on June 24, 2015 completed its offering pursuant to a registration statement filed on Form S-1. The Company issued 4,000,000 shares of its common stock to 26 investors. The investors paid $0.01 per share for a combined total investment of $40,000.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2015
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a. Basis of Accounting The Company’s financial statements are prepared using the accrual method of accounting. The Company elected a November 30 th b. Cash Equivalents For purposes of the balance sheet and statement of cash flows, the Company considers all liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents. c. Stock-based Compensation The Company follows ASC 718-10, Stock Compensation d. Use of Estimates and Assumptions Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates. e. Earnings (Loss) per Share The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the period. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company. f. Income Taxes Income taxes are provided in accordance with ASC 740, Income Taxes Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. No provision was made for Federal income tax. g. Revenue Recognition We will recognize revenues in accordance with ASC 605, Revenue Recognition h . Advertising Advertising is expensed in the period in which it is incurred. There has been no advertising expense in the reporting periods presented. i . Intangible Assets Intangible assets with finite lives are amortized over their estimated useful life. The Company monitors conditions related to these assets to determine whether events and circumstances warrant a revision to the remaining amortization period. The Company tests its intangible assets with finite lives for potential impairment whenever management concludes events or changes in circumstances indicate that the carrying amount may not be recoverable. The original estimate of an asset's useful life and the impact of an event or circumstance on either an asset's useful life or carrying value involve significant judgment. For the period November 25, 2014 (inception) through November 30, 2015 we recognized $1,000 in amortization expense. On November 25, 2014 we purchased a business plan from our founder along with product formula and commercially available micro-needle devices for use with the product formula in a tattoo removal process. j. Recently Issued Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09— Revenue from Contracts with Customers (Topic 606) Revenue Recognition In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements—Going Concern In February 2015, the FASB issued ASU 2015-02, Consolidation In April 2015, the FASB issued ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30) In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes Income Taxes Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Nov. 30, 2015
GOING CONCERN
GOING CONCERN	NOTE 3 – GOING CONCERN The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As reflected in the accompanying financial statements, the Company had negative working capital of $55,684 and an accumulated deficit of $76,107 at November 30, 2015. As of November 30, 2015, the Company had not generated revenues and had no committed sources of capital or financing. While the Company will attempt to generate revenues from services and products when fully developed, the Company’s cash position may not be significant enough to support the Company’s daily operations. Management believes implementation of its business plan provides the opportunity for the Company to continue as a going concern. While the Company believes in the viability of its business strategy and in its ability to raise additional funds, there can be no assurances that it will accomplish either. The Company’s ability to continue as a going concern is dependent upon its ability to achieve profitable operations or obtain adequate and sufficient financing. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

SHARE CAPITAL

SHARE CAPITAL	12 Months Ended
	Nov. 30, 2015
SHARE CAPITAL
SHARE CAPITAL	NOTE 4 – SHARE CAPITAL The Company is authorized to issue 100,000,000 shares of common stock ($0.001 par value) and 1,000,000 shares of preferred stock ($0.001 par value). The Company upon inception (November 25, 2014) issued 3,000,000 shares of its common stock to its incorporator (chief executive officer and president), for organizational services. These services were valued at $3,000. Following its formation, the Company issued 1,000,000 shares of common stock to its incorporator, as consideration for the purchase of a comprehensive business plan along with detailed product formula and commercially available micro-needle devices to be used with that product formula. Our incorporator, incurred approximately $1,000 in costs and or payments to develop and refine the tattoo removal process utilizing the product formula and micro-needle devices. The acquisition of the business plan, devices and product formula was valued at $1,000. The Company on June 24, 2015 completed its offering pursuant to a registration statement filed on Form S-1. The Company issued 4,000,000 shares of its common stock to 26 investors. The investors paid $0.01 per share for a total investment of $40,000. At November 30, 2015, there were 8,000,000 shares of common stock issued and outstanding. There are no shares of preferred stock issued or outstanding.

LOAN - RELATED PARTY

LOAN - RELATED PARTY	12 Months Ended
	Nov. 30, 2015
LOAN - RELATED PARTY
LOAN - RELATED PARTY	NOTE 5 – LOAN - RELATED PARTY As of November 30, 2015 the Company received $349 in loan proceeds from our founder, President and CEO. This related party loan was entered into to pay certain working capital expenses. The Company does not expect to repay this related party loan anytime soon. This loan is unsecured and carries no interest rate or a repayment term.

LOANS - NONRELATED PARTIES

LOANS - NONRELATED PARTIES	12 Months Ended
	Nov. 30, 2015
LOANS - NONRELATED PARTIES
LOANS - NONRELATED PARTIES	NOTE 6 – LOANS - NONRELATED PARTIES As of November 30, 2015 the Company owed $25,629 in loan proceeds to one nonrelated party. For the twelve months ended November 30, 2015 the Company received approximately $37,519 in proceeds from two nonrelated parties. For the twelve months ended November 30, 2015 the Company repaid total principal of $12,500 to two nonrelated parties. We secured two interest free loans from these two nonrelated parties in order to fund our working capital expenditures. With repayment of one nonrelated party loan the Company does not expect to have the ability to repay the other nonrelated party loan anytime soon. This nonrelated party loan is unsecured and carries no interest rate or repayment term.

DEFERRED OFFERING COSTS

DEFERRED OFFERING COSTS	12 Months Ended
	Nov. 30, 2015
DEFERRED OFFERING COSTS
DEFERRED OFFERING COSTS	NOTE 7 – DEFERRED OFFERING COSTS Deferred offering costs consist principally of accounting, legal and other fees incurred that were related to our common stock offering efforts. Deferred offering costs were offset against the net proceeds received from the offering. On June 24, 2015, deferred offering costs of $23,577 were credited towards additional paid in capital. Accounts payable include deferred offering costs of $2,500 which remains outstanding to our legal counsel at November 30, 2015.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Nov. 30, 2015
INCOME TAXES
INCOME TAXES	NOTE 8 – INCOME TAXES As of November 30, 2015, the Company had net operating loss carry forward of $76,107. This amount may be available to reduce future years’ taxable income. As of November 30, 2015 As of November 30, 2014 Deferred tax asset: Net operating tax carry-forward $ 26,637 $ 2,453 Other - - Gross deferred tax asset 26,637 2,453 Valuation allowance (26,637) (2,453) Net deferred tax asset $ - $ - Realization of deferred tax asset is dependent upon sufficient future taxable income during the period that deductible temporary differences and carry-forward is expected to be available to reduce taxable income. As the achievement of required future taxable income is uncertain, the Company recorded a valuation allowance.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2015
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS The Company evaluated all events that occurred after the balance sheet date of November 30, 2015 through the date these financial statements were issued. The Company determined that it has no reportable subsequent events.

ACCOUNTING POLICIES (Policies)

ACCOUNTING POLICIES (Policies)	12 Months Ended
	Nov. 30, 2015
Accounting Policies:
Basis of Accounting	a. Basis of Accounting The Company’s financial statements are prepared using the accrual method of accounting. The Company elected a November 30 th
Cash Equivalents	b. Cash Equivalents For purposes of the balance sheet and statement of cash flows, the Company considers all liquid instruments with maturity of three months or less at the time of issuance to be cash equivalents.
Stock-based Compensation	c. Stock-based Compensation The Company follows ASC 718-10, Stock Compensation
Use of Estimates and Assumptions	d. Use of Estimates and Assumptions Preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.
Earnings (Loss) per Share	e. Earnings (Loss) per Share The basic earnings (loss) per share is calculated by dividing the Company’s net income available to common shareholders by the weighted average number of common shares during the period. The diluted earnings (loss) per share is calculated by dividing the Company’s net income (loss) available to common shareholders by the diluted weighted average number of shares outstanding during the period. The diluted weighted average number of shares outstanding is the basic weighted number of shares adjusted for any potentially dilutive debt or equity. Diluted earnings (loss) per share are the same as basic earnings (loss) per share due to the lack of dilutive items in the Company.
Income Taxes, Policy	f. Income Taxes Income taxes are provided in accordance with ASC 740, Income Taxes Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. No provision was made for Federal income tax.
Revenue Recognition	g. Revenue Recognition We will recognize revenues in accordance with ASC 605, Revenue Recognition
Advertising	h . Advertising Advertising is expensed in the period in which it is incurred. There has been no advertising expense in the reporting periods presented.
Recently Issued Accounting Pronouncements	j. Recently Issued Accounting Pronouncements In May 2014, the FASB issued ASU 2014-09— Revenue from Contracts with Customers (Topic 606) Revenue Recognition In August 2014, the FASB issued ASU 2014-15, Presentation of Financial Statements—Going Concern In February 2015, the FASB issued ASU 2015-02, Consolidation In April 2015, the FASB issued ASU 2015-03, Interest—Imputation of Interest (Subtopic 835-30) In November 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes Income Taxes Other accounting standards that have been issued or proposed by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

SCHEDULE OF INCOME TAX BENEFIT

SCHEDULE OF INCOME TAX BENEFIT (Tables)	12 Months Ended
	Nov. 30, 2015
SCHEDULE OF INCOME TAX BENEFIT (Tables):
SCHEDULE OF INCOME TAX BENEFIT	As of November 30, 2015, the Company had net operating loss carry forward of $76,107. This amount may be available to reduce future years’ taxable income. As of November 30, 2015 As of November 30, 2014 Deferred tax asset: Net operating tax carry-forward $ 26,637 $ 2,453 Other - - Gross deferred tax asset 26,637 2,453 Valuation allowance (26,637) (2,453) Net deferred tax asset $ - $ -

ORGANIZATION (Details)

ORGANIZATION (Details) - USD ($)	Jun. 24, 2015	Nov. 25, 2014
Organization Details
Shares of common stock to its founder at inception in exchange for organizational costs		3,000,000
Shares of common stock issued to founder, as consideration for the purchase of a business plan along with several formulas and assorted selection of micro-needle devices for use		1,000,000
Amount paid by founder for product formula		$ 1,000
Value of acquisition		$ 1,000
Issued shares of common stock to 26 investors	4,000,000
Per share value of the shares issued to 26 investors	$ 0.001
Value of combined investment made by 26 investors	$ 40,000

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details)	12 Months Ended
	Nov. 30, 2015USD ($)
Intangible Assets Details
Amortization expense recorded	$ 1,000

GOING CONCERN (Details)

GOING CONCERN (Details)	Nov. 30, 2015USD ($)
Going Concern Details
Negative working capital	$ 55,684
Deficit accumulated	$ 76,107

SHARE CAPITAL TRANSACTIONS (Det

SHARE CAPITAL TRANSACTIONS (Details) - USD ($)	Nov. 30, 2015	Jun. 24, 2015	Nov. 25, 2014
Share Capital Transactions
Shares of common stock authorized			100,000,000
Par value of common stock			$ 0.001
Shares of preferred stock authorized			1,000,000
Par value of preferred stock			$ 0.001
Shares of common stock issued to incorporator (chief executive officer and president), for organization services			3,000,000
Value of the services and direct costs			$ 3,000
Shares of common stock issued to incorporator, as consideration for the purchase of a business plan along with several formulas and commercially available micro-needle devices			1,000,000
Amount incurred by incorporator is costs			$ 1,000
Value of acquisition of the business plan along with the devices and product formula			$ 1,000
Issued shares of common stock to 26 investors		4,000,000
Per share value of the shares issued to 26 investors		$ 0.001
Value of combined investment made by 26 investors		$ 40,000
Shares of common stock issued and outstanding	8,000,000

LOAN - RELATED PARTY (Details)

LOAN - RELATED PARTY (Details)	Nov. 30, 2015USD ($)
Loan - Related Party Details
Received loan proceeds from founder, President and CEO	$ 349

LOANS - NONRELATED PARTIES (Det

LOANS - NONRELATED PARTIES (Details)	Nov. 30, 2015USD ($)
Loans - Nonrelated parties Details
Loan proceeds owed to one nonrelated party	$ 25,629

DEFERRED OFFERING COSTS (Detail

DEFERRED OFFERING COSTS (Details) - USD ($)	Nov. 30, 2015	Jun. 24, 2015
Deferred Offering Costs Details
Deferred offering costs		$ 23,577
Deferred offering costs outstanding due to legal counsel, included in accounts payable	$ 2,500

INCOME TAXES NARRATIVE (Details

INCOME TAXES NARRATIVE (Details)	Nov. 30, 2015USD ($)
Income Taxes Narrative:
Net operating loss carry forward	$ 76,107

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	Nov. 30, 2015	Nov. 30, 2014
Deferred tax asset:
Net operating tax carry-forward	$ 26,637	$ 2,453
Other	0	0
Gross deferred tax asset	26,637	2,453
Valuation allowance	(26,637)	(2,453)
Net deferred tax asset	$ 0	$ 0